Adults with type 2 diabetes and microvascular complications have an increased risk for severe periodontitis compared with those without microvascular complications.
Read More »The Disease That May Be a Leading Cause of Death
Survey estimates that diabetes accounts for many more deaths in the United States than are being reported on death certificates — and that diabetes is actually the third leading cause of death.
Read More »Ertugliflozin Monotherapy in Patients with Type 2 Inadequately Controlled
Phase-3 study to evaluate efficacy and safety of ertugliflozin monotherapy.
Read More »Life Happens to Our Patients Too. Be Understanding.
Woman, type 1 diabetes, 63 years of age. Well-educated diabetes wise. Reached out to me saying: "HELP!! Normally I take 10 units of Toujeo at 9 pm. I did that last night. This morning I meant to take an additional 2 units because I'm not getting any exercise due to a knee injury. By mistake I took my usual dose of 10 units." Before I read the rest of her email, I thought, I know her. She knows what to do. She wears a CGM, she’ll be watching that. Then I read on...
Read More »Remission of Prediabetes to Normal Glucose Tolerance in Obese Adults
The use of a high protein diet instead of a high carbohydrate diet to help reverse the progression to diabetes.
Read More »Continuous Glucose Monitoring To Improve Diabetes Control
Two studies show use of sensor implanted under skin that continuously monitors glucose levels resulted in improved levels in T1 patients who inject insulin multiple times a day.
Read More »A New Combination Diabetes Treatment Could Become the Standard Instead of Insulin
Study shows significant improvement in diabetes control with a 1 point drop in A1c with less hypoglycemia.
Read More »Metformin Not the Only Treatment for Prediabetes
Pioglitazone in people with insulin resistance, prediabetes or diabetes is associated with a decreased risk for major adverse cardiovascular events, study data shows.
Read More »Metformin Reduces Mortality in CKD, CHF, and CLD
FDA label update will increase drug use in persons with historical contraindications or precautions.
Read More »Fenofibrate with a Statin in Type 2 Patients Reduces Long-Term Cardiovascular Risk
Using fibrates to treat hypertriglyceridemia has not shown significant benefit in cardiovascular mortality in previous studies.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.